KSE - Delayed Quote KRW

Pharmicell Co., Ltd. (005690.KS)

Compare
10,050.00
-50.00
(-0.50%)
At close: 3:30:23 PM GMT+9
Currency in KRW All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
56,589,908.90
56,227,378.92
60,181,806.97
51,811,620.50
37,752,047.60
Cost of Revenue
39,661,875.67
40,735,416.37
36,362,213
28,103,650.22
19,972,756.53
Gross Profit
16,928,033.23
15,491,962.55
23,819,593.97
23,707,970.28
17,779,291.07
Operating Expense
15,521,186
14,195,966
14,946,227
15,844,956
10,545,781
Operating Income
1,406,847.23
1,295,996.55
8,873,366.97
7,863,014.28
7,233,510.07
Net Non Operating Interest Income Expense
2,810,638.56
1,180,939.84
-415,372.71
-1,485,546.74
81,469.74
Pretax Income
4,564,405.16
4,732,057.18
5,968,957.59
9,450,907.16
5,241,801.25
Tax Provision
--
1,154,073.54
-2,292,811.23
--
--
Net Income Common Stockholders
3,410,331.61
3,577,983.63
8,261,768.82
9,450,907.16
5,241,801.25
Basic EPS
57.00
60.00
138.00
158.00
87.00
Diluted EPS
57.00
60.00
138.00
158.00
87.00
Basic Average Shares
59,898.14
59,633.06
59,867.89
59,815.87
60,250.59
Diluted Average Shares
59,898.14
59,633.06
59,867.89
59,815.87
60,250.59
Total Operating Income as Reported
1,406,846.63
1,295,996.45
8,873,366.50
7,862,970.35
7,233,378.53
Rent Expense Supplemental
--
--
--
59,009
139,869
Total Expenses
55,183,061.67
54,931,382.37
51,308,440
43,948,606.22
30,518,537.53
Net Income from Continuing & Discontinued Operation
3,410,331.61
3,577,983.63
8,261,768.82
9,450,907.16
5,241,801.25
Normalized Income
2,821,136.29
2,991,799.49
11,730,086.17
8,472,004.16
5,749,596.25
Interest Income
--
273,797
330,826
197,374
166,362
Interest Expense
--
866,883
746,199
1,682,921
84,893
Net Interest Income
2,810,638.56
1,180,939.84
-415,372.71
-1,485,546.74
81,469.74
EBIT
5,709,790.86
5,598,940.18
6,715,156.59
11,133,828.16
5,326,694.25
EBITDA
8,706,271.86
8,440,348.18
8,900,417.59
12,869,673.16
7,095,924.25
Reconciled Cost of Revenue
39,661,875.67
40,735,416.37
36,362,213
28,103,650.22
19,972,756.53
Reconciled Depreciation
2,996,481
2,841,408
2,185,261
1,735,845
1,769,230
Net Income from Continuing Operation Net Minority Interest
3,410,331.61
3,577,983.63
8,261,768.82
9,450,907.16
5,241,801.25
Total Unusual Items Excluding Goodwill
775,257
775,257
-4,783,886
1,305,204
-677,060
Total Unusual Items
775,257
775,257
-4,783,886
1,305,204
-677,060
Normalized EBITDA
7,931,014.86
7,665,091.18
13,684,303.59
11,564,469.16
7,772,984.25
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
186,061.68
189,072.86
-1,315,568.65
326,301
-169,265
12/31/2020 - 1/4/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade